HETLIOZ (TASIMELTEON) CAPSULES
associated with 86 other trademarks
Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasime...

Words that describe this trademark:

delayed sleep phase  autism spectrum disorder  spectrum disorder  treatment autism  pharmaceutical preparations  treatment  disorder  preparations 

Serial Number:

97357860

Mark:

HETLIOZ (TASIMELTEON) CAPSULES

Status:

First Extension-Granted

Status Date:

03-29-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive Disorder

Mark Description:

The mark consists of the word "HETLIOZ" on a first line, and "(TASIMELTEON) CAPSULES" on a second line, with an arc of eleven solid circles of increasing size connecting the first and second lines of text.

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

08-29-2023

Mark Drawing Status:

Design plus Words, Letters, and/or Numbers

Abandon Date:

N/A

Business Name:

HOFFMAN WARNICK LLC

Correspondent Name:

Recent Trademark filings by this company